North America In-Situ Hybridization Devices Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Upcoming Report
  • Jan 2020
  • North America
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

North America In-Situ Hybridization Devices Market By Technology (Fluorescence in-Situ Hybridization (FISH), Chromogenic in Situ Hybridization (CISH)), Probe Type (DNA, RNA), Device (Instruments, Consumables & Accessories, Software, Services), Application (Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Others), End User (Research & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic Institutes, CROs, Others),  Country (U.S., Canada, Mexico), Market Trends & Forecast to 2027

North America In-Situ Hybridization Devices Market

Market Analysis and Insights: North America In-Situ Hybridization Devices Market

In-situ hybridization devices market is expected to grow in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market for USD 449.89 million by 2027, growing at a CAGR of 5.46% over the above-mentioned forecast period. The growth of North America in-situ hybridization devices market is attributed to increasing occurrence of cancer in people.

In-situ hybridization uses a categorized probe of corresponding DNA, RNA or modified nucleic acid to contain a particular DNA or RNA sequence. In-situ hybridization, on the other hand, indicates the location of gene expression in their cellular context. There are two forms of in-situ hybridization, namely chromogenic in-situ hybridization (CISH) and fluorescence in-situ hybridization (FISH) which are used to classify the role of genes that provide useful insights into tumors.

In-situ hybridization is a powerful technique for distinguishing between different mRNA species within individual cells in tissue parts, providing insight into physiological processes and disease pathogenesis. Nevertheless, in-situ hybridization involves that a number of steps be taken with thorough optimization for each of the tissues examined and for each probe used. In order to preserve the target mRNA inside tissues, cross-linking fixatives are often needed. 

Raising cancer awareness along with technological advances in cancer therapy and increasing government initiatives are some of the key factors that will impact this markets growth in the forecast period of 2020 to 2027. High costs of research and development along with strict government regulations in process of approval hampering the market growth.

According to the National Cancer Institute, 1,685,210 new cases of cancer are projected to be diagnosed in 2016 and 595,690 cancer deaths are expected to occur in the United States alone. This has given rise to necessity of medical importance and introduced technologically advanced diagnostic procedures such as ISH for early detection of cancer. The growing scenario of cancer has also encouraged government agencies to build and invest in innovative testing alternatives.

The National Cancer Institute estimates that the U.S. government spending on cancer care was nearly USD 125 billion in 2010 and is projected to reach USD 156 billion in 2020.

This in-situ hybridization devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on in-situ hybridization devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.   

North America In-Situ Hybridization Devices Market Scope and Market Size

In-situ hybridization devices market is segmented on the basis of technology, probe type, device, application and end user. Such categories allow you to evaluate progress in different niche exchanges and consumer strategy approaches and define the main areas of operation, as well as help you uncover the main difference between your target markets.

  • Based on the technology, North America in-situ hybridization devices market is mainly segmented into fluorescence in-situ hybridization (FISH) and chromogenic in-situ hybridization (CISH).
  • Based on the probe type, North America in-situ hybridization devices market is segmented into two categories DNA and RNA.
  • Based on the device, North America in-situ hybridization devices market is divided into three notable segments that are instruments, consumables & accessories, services and software. North America in-situ hybridization devices market is further segmented on the basis of instruments into hybridizer, imaging and microscopy instruments.
  • Based on application, Europe in-situ hybridization devices market is segmented into cancer, cytogenetics, developmental biology, infectious diseases and others.
  • Based on the end user, North America in-situ hybridization devices market is segmented into research & diagnostic laboratories, pharmaceutical & biotechnology companies, academic institutes, CROs and others.

In-Situ Hybridization Devices Market Country Level Analysis

In-situ hybridization devices market is analysed and market size information is provided by country, technology, probe type, device, application and end user as referenced above. The countries covered in North America in-situ hybridization devices market report are U.S., Canada and Mexico.

The country section of the artificial organs market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

North America in-situ hybridization devices market report also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America in-situ hybridization devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America in-situ hybridization devices market. The data is available for the historic period of 2010 to 2018.

Competitive Landscape and In-Situ Hybridization Devices Market Share Analysis

In-situ hybridization devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to in-situ hybridization devices market.

The major players of North America in-situ hybridization devices market covered in the report are Abbott, F. Hoffmann-La Roche Ltd, BioGenex, Merck KGaA, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer Inc., Danaher, Sysmex Corporation, Bio-Techne, Advanced Cell Diagnostics, Inc., Bio SB, Oxford Gene Technology, LGC Biosearch Technologies, Genemed Biotechnologies, Inc., Bio-Rad Laboratories, Inc., NeoGenomics Laboratories, Inc. among other regional and domestic players.

  • In July 2019, Bio-Techne announced the extension of the Advanced Cell Diagnostics RNAscope program with the launch of the HiPlex Assay RNAscope. The RNAscope Platform is an integrated in-situ hybridization technique that enables the simulation of single-molecule gene expression with single-cell resolution directly in intact tissues. With this expansion the company will expand its product portfolio as well as increase its market size which further helps to increase sales & revenue of the company. 

The market share data in this report is available only for North America in-situ hybridization devices market. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: North America In-Situ Hybridization Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19